CS119592A3 - N-hydroxy-n-/3-/in position 2-substituted phenyl/prop-2-enyl/urea andthiourea and a pharmaceutical composition comprising thereof - Google Patents

N-hydroxy-n-/3-/in position 2-substituted phenyl/prop-2-enyl/urea andthiourea and a pharmaceutical composition comprising thereof Download PDF

Info

Publication number
CS119592A3
CS119592A3 CS921195A CS119592A CS119592A3 CS 119592 A3 CS119592 A3 CS 119592A3 CS 921195 A CS921195 A CS 921195A CS 119592 A CS119592 A CS 119592A CS 119592 A3 CS119592 A3 CS 119592A3
Authority
CS
Czechoslovakia
Prior art keywords
hydroxy
phenyl
prop
enyl
carbon atoms
Prior art date
Application number
CS921195A
Other languages
Czech (cs)
English (en)
Inventor
Gary Alan Hite
Edward David Mihelich
David Wells Snyder
Tulio Suarez
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CS119592A3 publication Critical patent/CS119592A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS921195A 1991-04-23 1992-04-17 N-hydroxy-n-/3-/in position 2-substituted phenyl/prop-2-enyl/urea andthiourea and a pharmaceutical composition comprising thereof CS119592A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/690,131 US5130485A (en) 1991-04-23 1991-04-23 N-hydroxy-N-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas useful as 5-lipoxygenase inhibiting agents

Publications (1)

Publication Number Publication Date
CS119592A3 true CS119592A3 (en) 1992-12-16

Family

ID=24771221

Family Applications (1)

Application Number Title Priority Date Filing Date
CS921195A CS119592A3 (en) 1991-04-23 1992-04-17 N-hydroxy-n-/3-/in position 2-substituted phenyl/prop-2-enyl/urea andthiourea and a pharmaceutical composition comprising thereof

Country Status (19)

Country Link
US (1) US5130485A (es)
EP (1) EP0510947A1 (es)
JP (1) JPH05148218A (es)
KR (1) KR920019739A (es)
CN (1) CN1066060A (es)
AU (1) AU647911B2 (es)
BR (1) BR9201451A (es)
CA (1) CA2066509A1 (es)
CS (1) CS119592A3 (es)
FI (1) FI921785A (es)
HU (1) HU209794B (es)
IE (1) IE921280A1 (es)
IL (1) IL101624A0 (es)
MX (1) MX9201809A (es)
NO (1) NO921529L (es)
NZ (1) NZ242427A (es)
TW (1) TW215081B (es)
YU (1) YU42592A (es)
ZA (1) ZA922872B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283361A (en) * 1991-04-23 1994-02-01 Eli Lilly And Company N-hydroxy-N-[3-[2-(halophenylthio)phenyl]prop-2-enyl]ureas as lipoxygenase inhibitors
US5288743A (en) * 1992-11-20 1994-02-22 Abbott Laboratories Indole carboxylate derivatives which inhibit leukotriene biosynthesis
US5891460A (en) * 1995-06-07 1999-04-06 University Of Southern California University Park Campus Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof
NZ720946A (en) 2009-04-29 2017-09-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
US11724991B1 (en) * 2023-01-06 2023-08-15 King Faisal University Selective 5-LO inhibitors for the treatment of bronchial asthma

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE59397B1 (en) * 1985-03-16 1994-02-23 Wellcome Found New aryl derivatives
AU602485B2 (en) * 1985-03-16 1990-10-18 Wellcome Foundation Limited, The Lipoxygenase and/or cyclooxygenase inhibitory compounds
GB8619593D0 (en) * 1986-08-12 1986-09-24 Roussel Lab Ltd Chemical compounds
US4897422A (en) * 1987-02-10 1990-01-30 Abbott Laboratories Lipoxygenase inhibiting compounds
DE3882732T2 (de) * 1987-02-10 1993-12-02 Abbott Lab Indol, Benzofuran, Benzothiophen enthaltende, Lipoxygenase hemmende Verbindungen.
EP0292699B1 (en) * 1987-04-24 1994-03-23 Abbott Laboratories Urea based lipoxygenase inhibiting compounds
PT93049A (pt) * 1989-02-03 1990-08-31 Wellcome Found Processo para a preparacao de compostos de aril-hidroxi-ureia possuindo actividade anti-inflamatoria e de composicoes farmaceuticas que os contem
EP0588785A1 (en) * 1989-03-30 1994-03-30 Abbott Laboratories Urea based lipoxygenase inhibiting compounds

Also Published As

Publication number Publication date
NZ242427A (en) 1993-11-25
NO921529D0 (no) 1992-04-21
US5130485A (en) 1992-07-14
CA2066509A1 (en) 1992-10-24
HUT61978A (en) 1993-03-29
IL101624A0 (en) 1992-12-30
HU9201342D0 (en) 1992-07-28
FI921785A0 (fi) 1992-04-22
HU209794B (en) 1994-11-28
JPH05148218A (ja) 1993-06-15
AU1501692A (en) 1992-10-29
IE921280A1 (en) 1992-11-04
TW215081B (es) 1993-10-21
AU647911B2 (en) 1994-03-31
FI921785A (fi) 1992-10-24
BR9201451A (pt) 1992-12-01
CN1066060A (zh) 1992-11-11
ZA922872B (en) 1993-10-21
KR920019739A (ko) 1992-11-19
YU42592A (sh) 1995-01-31
MX9201809A (es) 1994-05-31
NO921529L (no) 1992-10-26
EP0510947A1 (en) 1992-10-28

Similar Documents

Publication Publication Date Title
US5105017A (en) Leukotriene antagonist intermediates
CA1329613C (en) Leukotriene antagonists
EP0276064B1 (en) Anti-inflammatory agents
EP0125783B1 (en) Dopamine-beta-hydroxylase inhibitors
EP0132367B1 (en) Leukotriene antagonists
JPH0637443B2 (ja) １−フェニル−３−ナフタレニルオキシプロパンアミン類
US5028629A (en) 5-Lipoxygenase inhibitors
CS119592A3 (en) N-hydroxy-n-/3-/in position 2-substituted phenyl/prop-2-enyl/urea andthiourea and a pharmaceutical composition comprising thereof
US5283361A (en) N-hydroxy-N-[3-[2-(halophenylthio)phenyl]prop-2-enyl]ureas as lipoxygenase inhibitors
AU610218B2 (en) Improvements in or relating to leukotriene antagonists
US4764521A (en) Leukotriene antagonists and a method of use there as
CA1336287C (en) Selective serotonin uptake inhibitors
EP0288190B1 (en) Improvements in or relating to leukotriene antagonists
EP0083204A2 (en) 2-Aminophenol derivatives and process for their preparation
US4562199A (en) Imidazole derivatives, compositions and use
EP0106060B1 (en) Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations
JP2003176264A (ja) シクロオキシゲナーゼ−２阻害剤として選択性の優れた３，４−ジヒドロ−１ｈ−ナフタレン誘導体